Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils

Immunology

Volumn 111, Issue 2, 2004, Pages 186-194

  Kamohara, Hidenobu ^a   Matsuyama, Wataru ^a   Shimozato, Osamu ^a   Abe, Koichiro ^a   Gallican, Carole ^a   Hashimoto, Shin Ichi ^b   Matsushima, Kouji ^b   Yoshimura, Teizo ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CELL INFILTRATION; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIBODIES, MONOCLONAL; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; MEMBRANE GLYCOPROTEINS; NEUTROPHILS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; RNA, MESSENGER; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR DECOY RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0842287210     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0019-2805.2003.01794.x     Document Type: Article

References (33)

1. Wiley SR, Schooley K, Smolak PJ et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995; 3:673-82.
2. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 1996; 271:12687-90.
3. Ashkenazi A, Dixit V. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999; 11:255-60.
4. Griffith TS, Lynch DH. TRAIL: a molecule with multiple receptors and control mechanisms. Curr Opin immunol 1998; 10:559-63.
5. Sedger LM, Shows DM, Blanton RA, Peschon JJ, Goodwin RG, Cosman D, Wiley SR. IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J Immunol 1999; 163:920-6.
6. Thomas WD, Hersey P. TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells. J Immunol 1998; 161:2195-200.
7. Kayagaki N, Yamaguchi N, Nakayama M, Eto H, Okumura K, Yagita H. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells. A novel mechanism for the antitumor effects of type IIFNs. J Exp Med 1999; 189:1451-60.
8. Griffith TS, Wiley SR, Kubin MZ, Sedger LM, Maliszewski CR, Fanger NA. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J Exp Med 1999; 189:1343-53.
9. Fanger NA, Maliszewski CR, Schooley K, Griffith TS. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Exp Med 1999; 190:1155-64.
10. Zamai L, Ahmad M, Bennett IM, Azzoni L, Alnemri ES, Perussia B. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J Exp Med 1998; 188:2375-80.
11. Johnsen AC, Haux J, Steinkjer B, Nonstad U, Egeberg K, Sundan A, Ashkenazi A, Espevik T. Regulation of APO-2 ligand/trail expression in NK cells - involvement in NK cell-mediated cytotoxicity. Cytokine 1999; 11:664-72.
12. Smyth MJ, Takeda K, Hayakawa Y, Peschon JJ, van den Brink MR, Yagita H. Nature's TRAIL - on a path to cancer immunotherapy. Immunity 2003; 18:1-6.
13. -/- mice. Nat Immunol 2003; 4:255-60.
14. Hamlin IME. Possible host resistance in carcinoma of the breast: a histological study. Br J Cancer 1968; 22:383-401.
15. Black MM, Barclay THC, Hankey BF. Prognosis in breast cancer utilizing histological characteristics of the primary tumor. Cancer 1975; 36:2048-55.
16. Bassler T, Dittman AM, Dittrich M. Mononuclear stromal reactions in mammary carcinoma, with reference to medullary carcinomas with a lymphoid infiltrate. Virchow Arch A Pathol Anat Histol 1981; 393:75-91.
17. Pekarek LA, Starr BA, Toledano AY, Schreiber H. Inhibition of tumor growth by elimination of granulocytes. J Exp Med 1995; 181:435-40.
18. Di Carlo E, Forni G, Lollini P, Colombo MP, Modesti A, Musiani P. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 2001; 97:339-45.
19. Renshaw SA, Parmar JS, Singleton V et al. Acceleration of human neutrophil apoptosis by TRAIL. J Immunol 2003; 170:1027-33.
20. Daigle I, Simon H-U. Alternative functions for TRAIL receptors in eosinophils and neutrophils. Swiss Med Wkly 2001; 131: 231-7.
21. Daigle I, Yousefi S, Colonna M, Green DR, Simon H-U. Death receptors bind SHP-1 and block cytokine-induced anti-apoptotic signaling in neutrophils. Nat Med 2002; 8:61-7.
22. Xu LL, McVicar DW, Ben-Baruch A, Kuhns DB, Johnston J, Oppenheim JJ, Wang JM. Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors: binding and signaling of MCP3 through shared as well as unique receptors on monocytes and neutrophils. Eur J Immunol 1995; 25:2612-7.
23. Yoshimura T. cDNA cloning of guinea pig monocyte chemoattractant protein-1 and expression of the recombinant protein. J Immunol 1993; 150:5025-32.
24. Murray J, Barbara JAJ, Dunkley SA et al. Regulation of neutrophil apoptosis by tumor necrosis factor-alpha. Requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro. Blood 1997; 90:2772-83.
25. Salamone G, Giordano M, Trevani AS, Gamberale R, Vermeulen M, Schettinni J, Geffner JR. Promotion of neutrophil apoptosis by TNF-α. J Immunol 2001; 166:3476-83.
26. Smyth MJ, Cretney E, Takeda K, Wiltrout RH, Sedger LM, Kayagaki N, Yagita H, Okumura K. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon-α-dependent natural killer cell protection from tumor metastasis. J Exp Med 2001; 193:661-70.
27. Halaas O, Vik R, Ashkenazi A, Espevik T. Lipopolysaccharide induces expression of APO2 ligand/TRAIL in human monocytes and macrophages. Scand J Immunol 2000; 51:244-50.
28. Kayagaki N, Kawasaki A, Ebata Tet al. Metalloproteinase-mediated release of human Fas ligand. J Exp Med 1995; 182:1777-83.
29. Cassatella MA. Neutrophil-derived proteins: selling cytokines by the pound. Adv Immunol 1999; 73:369-509.
30. Yamashiro S, Kamohara H, Yoshimura T. MCP-1 is selectively expressed in the late phase by cytokine-stimulated human neutrophils: TNF-α plays a role in the maximal MCP-1 mRNA expression. J Leukoc Biol 1999; 65:671-9.
31. Dubravec DB, Spriggs DR, Mannick JA, Rodrick ML. Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor. Proc Natl Acad Sci USA 1990; 87: 6758-61.
32. Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, Schreiber RD. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci USA 1998; 95:7556-61.
33. Chou AH, Tsai HF, Lin LL, Hsieh SL, Hsu PI, Hsu PN. Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand. J Immunol 2001; 167:1347-52.